{"product_id":"ck6-antibody-sc-f3320","title":"Cytokeratin 6 Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eCK6 is a target of interest in many antibody-based workflows. Cytokeratin 6 (Keratin 6 (K6)) is a type II intermediate filament (IF) protein that exists in two main isoforms, K6a and K6b, and plays a critical role in epithelial tissue integrity and wound repair. Under normal conditions, K6 expression is limited to ectoderm-derived epithelial appendages such as hair follicles, nails, and glands, as well as palmar and plantar epidermis. Depending on the literature source, CK6 may also be discussed as Cytokeratin 6.\u003c\/p\u003e\u003cp\u003eReported cellular context includes intermediate filament and keratin, which can matter when signal is compared across treatments or changing cell states. Following CK6 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eCK6 is commonly interpreted in the context of immunology research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans intermediate filament and keratin, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between intermediate filament and keratin across matched conditions\u003c\/li\u003e\n\u003cli\u003econtext differences tied to immune-cell state, activation, or lineage composition\u003c\/li\u003e\n\u003cli\u003eco-patterning with orthogonal markers and control conditions that clarify pathway state\u003c\/li\u003e\n\u003cli\u003etime-matched comparisons so changes reflect biology rather than handling or sampling drift\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for CK6. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in CK6 reflect biology rather than handling. When interpreting CK6, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep CK6 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57578014671193,"sku":"F3320-20UL","price":199.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57578014703961,"sku":"F3320-100UL","price":489.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57578014736729,"sku":"F3320-2X100UL","price":729.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F3320-IF.png?v=1773601108","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/ck6-antibody-sc-f3320","provider":"Absource Diagnostics","version":"1.0","type":"link"}